Rabais 4Saisons Inc. Unauthorized Drugs Recall
Areazine synthesizes this Health Canada recall directly from Health Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
Health Canada seized unauthorized drugs from Rabais 4Saisons Inc. in Montreal that may pose serious health risks due to lack of approval and potential contamination or incorrect ingredients.
What this Health Canada recall tells you, and what most readers miss
This notice was issued by Health Canada on August 18, 2026 and geographically references Montreal, QC. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Product & Food Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, health-canada, drugs.
What Happened
Health Canada has seized several unauthorized drugs from Rabais 4Saisons Inc. (5321 rue de Charleroi) in Montreal, Quebec, because they may pose serious health risks. Selling unauthorized health products in Canada is illegal, and these products have not been assessed for safety, effectiveness, or quality.
Which Products Are Affected
Various unauthorized health products were seized, including:
- After-D (labelled to contain levonorgestrel)
- Albendazol (labelled to contain albendazole)
- Balaxi – Amoxicilina (labelled to contain amoxicillin)
- Balaxi – Tetraciclina (labelled to contain tetracycline)
- Black Horse Vital Honey (product with similar packaging previously tested and found to contain sildenafil)
- Caplin Point (labelled to contain ampicillin)
- Erix (labelled to contain sildenafil)
- Saad – Ampicilina (labelled to contain ampicillin)
These include an oral emergency contraceptive drug, erectile dysfunction drugs, and antibiotic and antiparasitic drugs. Many are unauthorized versions of prescription drugs and are not labelled in English and French as required.
What You Should Do
Do not buy or use unauthorized health products. Consult with a licensed healthcare professional (physician, nurse practitioner, pharmacist) if you have used these products and have health concerns. Check if health products are authorized by looking for an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN), or Homeopathic Drug Number (DIN-HM), or search Health Canada's Drug Product Database or Licensed Natural Health Products Database. Report any health product-related side effects or complaints to Health Canada.
Why This Matters
Unauthorized health products may lack active ingredients, vary in concentration, or contain unlisted or contaminated ingredients that could interact with medications and foods, posing serious health risks including severe allergic reactions or organ damage.
Source
https://recalls-rappels.canada.ca/en/alert-recall/unauthorized-drugs-seized-rabais-4saisons-inc-montreal-qc-may-pose-serious-health - Health Canada
Original source: Health Canada Official Notice ↗
Related Product & Food Recalls
All Product & Food Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (2,244 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to August 18, 2026.
Frequently Asked Questions
Common questions about this Health Canada recall.